161 related articles for article (PubMed ID: 2550989)
1. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
Herberg LJ; Rose IC
Psychopharmacology (Berl); 1989; 99(1):87-90. PubMed ID: 2550989
[TBL] [Abstract][Full Text] [Related]
2. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
Marrannes R; Willems R; De Prins E; Wauquier A
Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
[TBL] [Abstract][Full Text] [Related]
4. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
[TBL] [Abstract][Full Text] [Related]
5. Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801).
Lyle TA; Magill CA; Britcher SF; Denny GH; Thompson WJ; Murphy JS; Knight AR; Kemp JA; Marshall GR; Middlemiss DN
J Med Chem; 1990 Mar; 33(3):1047-52. PubMed ID: 2155319
[TBL] [Abstract][Full Text] [Related]
6. Possible abuse potential of the NMDA antagonist MK-801.
Corbett D
Behav Brain Res; 1989 Sep; 34(3):239-46. PubMed ID: 2551338
[TBL] [Abstract][Full Text] [Related]
7. The effect of the NMDA receptor antagonist, MK-801, on the course and outcome of kindling.
Mintz M; Rose IC; Herberg LJ
Pharmacol Biochem Behav; 1990 Apr; 35(4):815-21. PubMed ID: 2161108
[TBL] [Abstract][Full Text] [Related]
8. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Koek W; Woods JH; Winger GD
J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
[TBL] [Abstract][Full Text] [Related]
9. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
Foster AC; Wong EH
Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
[TBL] [Abstract][Full Text] [Related]
10. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.
France CP; Woods JH; Ornstein P
Eur J Pharmacol; 1989 Jan; 159(2):133-9. PubMed ID: 2651134
[TBL] [Abstract][Full Text] [Related]
11. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
[TBL] [Abstract][Full Text] [Related]
12. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801.
Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH
Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964
[TBL] [Abstract][Full Text] [Related]
13. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.
Daniell LC
Pharmacol Biochem Behav; 1990 May; 36(1):111-5. PubMed ID: 2190239
[TBL] [Abstract][Full Text] [Related]
14. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
15. Noncompetitive N-methyl-D-aspartate antagonists affect multiple ionic currents.
Rothman S
J Pharmacol Exp Ther; 1988 Jul; 246(1):137-42. PubMed ID: 2455788
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture.
Halliwell RF; Peters JA; Lambert JJ
Br J Pharmacol; 1989 Feb; 96(2):480-94. PubMed ID: 2647206
[TBL] [Abstract][Full Text] [Related]
17. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
Gilbert ME
Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
[TBL] [Abstract][Full Text] [Related]
18. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.
Koek W; Colpaert FC
J Pharmacol Exp Ther; 1990 Jan; 252(1):349-57. PubMed ID: 2153806
[TBL] [Abstract][Full Text] [Related]
19. MK-801 prevents cognitive and behavioral deficits produced by NMDA receptor overstimulation in the rat hippocampus.
Rogers BC; Tilson HA
Toxicol Appl Pharmacol; 1989 Jul; 99(3):445-53. PubMed ID: 2546291
[TBL] [Abstract][Full Text] [Related]
20. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
Goldberg MP; Viseskul V; Choi DW
J Pharmacol Exp Ther; 1988 Jun; 245(3):1081-7. PubMed ID: 2838603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
